William Blair downgraded shares of Cross Country Healthcare (NASDAQ:CCRN – Free Report) from a strong-buy rating to a hold rating in a research report report published on Wednesday,Zacks.com reports.
A number of other research analysts have also issued reports on CCRN. Benchmark lowered Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday. Barrington Research lowered their price objective on shares of Cross Country Healthcare from $21.00 to $19.00 and set an “outperform” rating on the stock in a research note on Thursday, August 8th. Finally, Truist Financial increased their target price on shares of Cross Country Healthcare from $15.00 to $18.61 and gave the company a “hold” rating in a research note on Thursday. Three equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, Cross Country Healthcare currently has a consensus rating of “Hold” and a consensus price target of $18.54.
Get Our Latest Analysis on Cross Country Healthcare
Cross Country Healthcare Trading Up 0.1 %
Hedge Funds Weigh In On Cross Country Healthcare
Institutional investors and hedge funds have recently modified their holdings of the stock. SummerHaven Investment Management LLC grew its stake in Cross Country Healthcare by 3.8% in the second quarter. SummerHaven Investment Management LLC now owns 28,376 shares of the business services provider’s stock valued at $393,000 after purchasing an additional 1,032 shares in the last quarter. Raymond James & Associates grew its stake in shares of Cross Country Healthcare by 0.7% in the 2nd quarter. Raymond James & Associates now owns 165,324 shares of the business services provider’s stock valued at $2,288,000 after buying an additional 1,155 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Cross Country Healthcare by 14.0% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,169 shares of the business services provider’s stock valued at $137,000 after buying an additional 1,250 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in Cross Country Healthcare by 9.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 16,639 shares of the business services provider’s stock worth $312,000 after buying an additional 1,450 shares during the last quarter. Finally, Gladius Capital Management LP raised its position in Cross Country Healthcare by 83.4% during the third quarter. Gladius Capital Management LP now owns 3,985 shares of the business services provider’s stock valued at $54,000 after acquiring an additional 1,812 shares in the last quarter. 96.03% of the stock is currently owned by hedge funds and other institutional investors.
About Cross Country Healthcare
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Recommended Stories
- Five stocks we like better than Cross Country Healthcare
- How to Plot Fibonacci Price Inflection Levels
- Trinity Capital CEO on Leading Private Credit’s High-Yield Growth
- Canada Bond Market Holiday: How to Invest and Trade
- Lululemon Surges On Q3 Report: Analysts Step in To Support Market
- What is a Special Dividend?
- 10 Safe Investments with High Returns
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.